Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-17

Clinical Trial Update: Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating varenicline (Chantix) for waterpipe smoking cessation in nicotine dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Nicotine Dependence | Phase 4 | Status: COMPLETED